Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1.

Matte A, Recchiuti A, Federti E, Koehl B, Mintz T, El Nemer W, Tharaux PL, Brousse V, Andolfo I, Lamolinara A, Weinberg O, Siciliano A, Norris PC, Riley IR, Iolascon A, Serhan CN, Brugnara C, De Franceschi L.

Blood. 2019 Jan 17;133(3):252-265. doi: 10.1182/blood-2018-07-865378. Epub 2018 Nov 7.

PMID:
30404812
2.

Genotype-phenotype correlation and risk stratification in a cohort of 123 hereditary stomatocytosis patients.

Andolfo I, Russo R, Rosato BE, Manna F, Gambale A, Brugnara C, Iolascon A.

Am J Hematol. 2018 Dec;93(12):1509-1517. doi: 10.1002/ajh.25276. Epub 2018 Oct 2.

PMID:
30187933
3.

Label-Free Optical Marker for Red-Blood-Cell Phenotyping of Inherited Anemias.

Mugnano M, Memmolo P, Miccio L, Merola F, Bianco V, Bramanti A, Gambale A, Russo R, Andolfo I, Iolascon A, Ferraro P.

Anal Chem. 2018 Jun 19;90(12):7495-7501. doi: 10.1021/acs.analchem.8b01076. Epub 2018 Jun 4.

PMID:
29792684
4.

Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias.

Russo R, Andolfo I, Manna F, Gambale A, Marra R, Rosato BE, Caforio P, Pinto V, Pignataro P, Radhakrishnan K, Unal S, Tomaiuolo G, Forni GL, Iolascon A.

Am J Hematol. 2018 May;93(5):672-682. doi: 10.1002/ajh.25058. Epub 2018 Feb 24.

PMID:
29396846
5.

PIEZO1-R1864H rare variant accounts for a genetic phenotype-modifier role in dehydrated hereditary stomatocytosis.

Andolfo I, Manna F, De Rosa G, Rosato BE, Gambale A, Tomaiuolo G, Carciati A, Marra R, De Franceschi L, Iolascon A, Russo R.

Haematologica. 2018 Mar;103(3):e94-e97. doi: 10.3324/haematol.2017.180687. Epub 2017 Nov 30. No abstract available.

6.

Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis.

Federti E, Matte A, Ghigo A, Andolfo I, James C, Siciliano A, Leboeuf C, Janin A, Manna F, Choi SY, Iolascon A, Beneduce E, Melisi D, Kim DW, Levi S, De Franceschi L.

Data Brief. 2017 Sep 30;15:376-381. doi: 10.1016/j.dib.2017.09.062. eCollection 2017 Dec.

7.

Hereditary stomatocytosis: An underdiagnosed condition.

Andolfo I, Russo R, Gambale A, Iolascon A.

Am J Hematol. 2018 Jan;93(1):107-121. doi: 10.1002/ajh.24929. Epub 2017 Oct 23. Review.

8.

Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension.

Federti E, Matté A, Ghigo A, Andolfo I, James C, Siciliano A, Leboeuf C, Janin A, Manna F, Choi SY, Iolascon A, Beneduce E, Melisi D, Kim DW, Levi S, De Franceschi L.

Free Radic Biol Med. 2017 Nov;112:376-386. doi: 10.1016/j.freeradbiomed.2017.08.004. Epub 2017 Aug 9.

PMID:
28801243
9.

Targeted next generation sequencing identifies a novel β-spectrin gene mutation A2059P in two Omani children with hereditary pyropoikilocytosis.

Al-Riyami AZ, Iolascon A, Al-Zadjali S, Andolfo I, Al-Mammari S, Manna F, Al Rawas A, King MJ, Russo R.

Am J Hematol. 2017 Oct;92(10):E607-E609. doi: 10.1002/ajh.24853. Epub 2017 Jul 29. No abstract available.

10.

GATA1 erythroid-specific regulation of SEC23B expression and its implication in the pathogenesis of congenital dyserythropoietic anemia type II.

Russo R, Andolfo I, Gambale A, De Rosa G, Manna F, Arillo A, Wandroo F, Bisconte MG, Iolascon A.

Haematologica. 2017 Sep;102(9):e371-e374. doi: 10.3324/haematol.2016.162966. Epub 2017 May 26. No abstract available.

11.

Recommendations regarding splenectomy in hereditary hemolytic anemias.

Iolascon A, Andolfo I, Barcellini W, Corcione F, Garçon L, De Franceschi L, Pignata C, Graziadei G, Pospisilova D, Rees DC, de Montalembert M, Rivella S, Gambale A, Russo R, Ribeiro L, Vives-Corrons J, Martinez PA, Kattamis A, Gulbis B, Cappellini MD, Roberts I, Tamary H; Working Study Group on Red Cells and Iron of the EHA.

Haematologica. 2017 Aug;102(8):1304-1313. doi: 10.3324/haematol.2016.161166. Epub 2017 May 26.

12.

New insights on hereditary erythrocyte membrane defects.

Andolfo I, Russo R, Gambale A, Iolascon A.

Haematologica. 2016 Nov;101(11):1284-1294. Epub 2016 Oct 18. Review.

13.

Increased levels of ERFE-encoding FAM132B in patients with congenital dyserythropoietic anemia type II.

Russo R, Andolfo I, Manna F, De Rosa G, De Falco L, Gambale A, Bruno M, Mattè A, Ricchi P, Girelli D, De Franceschi L, Iolascon A.

Blood. 2016 Oct 6;128(14):1899-1902. doi: 10.1182/blood-2016-06-724328. Epub 2016 Aug 18. No abstract available.

14.

Functional characterization of novel ABCB6 mutations and their clinical implications in familial pseudohyperkalemia.

Andolfo I, Russo R, Manna F, De Rosa G, Gambale A, Zouwail S, Detta N, Pardo CL, Alper SL, Brugnara C, Sharma AK, De Franceschi L, Iolascon A.

Haematologica. 2016 Aug;101(8):909-17. doi: 10.3324/haematol.2016.142372. Epub 2016 May 5.

15.

Next generation research and therapy in red blood cell diseases.

Russo R, Andolfo I, Iolascon A.

Haematologica. 2016 May;101(5):515-7. doi: 10.3324/haematol.2015.139238. No abstract available.

16.

Diagnosis and management of congenital dyserythropoietic anemias.

Gambale A, Iolascon A, Andolfo I, Russo R.

Expert Rev Hematol. 2016 Mar;9(3):283-96. doi: 10.1586/17474086.2016.1131608. Epub 2016 Jan 6. Review.

PMID:
26653117
17.

Novel Gardos channel mutations linked to dehydrated hereditary stomatocytosis (xerocytosis).

Andolfo I, Russo R, Manna F, Shmukler BE, Gambale A, Vitiello G, De Rosa G, Brugnara C, Alper SL, Snyder LM, Iolascon A.

Am J Hematol. 2015 Oct;90(10):921-6. doi: 10.1002/ajh.24117.

18.

Inhibition of hypoxia inducible factors combined with all-trans retinoic acid treatment enhances glial transdifferentiation of neuroblastoma cells.

Cimmino F, Pezone L, Avitabile M, Acierno G, Andolfo I, Capasso M, Iolascon A.

Sci Rep. 2015 Jun 9;5:11158. doi: 10.1038/srep11158.

19.

Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease.

Kalish BT, Matte A, Andolfo I, Iolascon A, Weinberg O, Ghigo A, Cimino J, Siciliano A, Hirsch E, Federti E, Puder M, Brugnara C, De Franceschi L.

Haematologica. 2015 Jul;100(7):870-80. doi: 10.3324/haematol.2015.124586. Epub 2015 May 1.

20.

Red cells in post-genomic era: impact of personalized medicine in the treatment of anemias.

Iolascon A, Andolfo I, Russo R.

Haematologica. 2015 Jan;100(1):3-6. doi: 10.3324/haematol.2014.120733. No abstract available.

21.

Retrospective cohort study of 205 cases with congenital dyserythropoietic anemia type II: definition of clinical and molecular spectrum and identification of new diagnostic scores.

Russo R, Gambale A, Langella C, Andolfo I, Unal S, Iolascon A.

Am J Hematol. 2014 Oct;89(10):E169-75. doi: 10.1002/ajh.23800. Epub 2014 Jul 22.

22.

Hereditary xerocytosis revisited.

Archer NM, Shmukler BE, Andolfo I, Vandorpe DH, Gnanasambandam R, Higgins JM, Rivera A, Fleming MD, Sachs F, Gottlieb PA, Iolascon A, Brugnara C, Alper SL, Nathan DG.

Am J Hematol. 2014 Dec;89(12):1142-6. doi: 10.1002/ajh.23799. Epub 2014 Jul 21. No abstract available.

23.

Trasferrin receptor 2 gene regulation by microRNA 221 in SH-SY5Y cells treated with MPP⁺ as Parkinson's disease cellular model.

Asci R, Vallefuoco F, Andolfo I, Bruno M, De Falco L, Iolascon A.

Neurosci Res. 2013 Nov;77(3):121-7. doi: 10.1016/j.neures.2013.09.003. Epub 2013 Sep 17.

PMID:
24055409
24.

Rapid Cl⁻/HCO⁻₃exchange kinetics of AE1 in HEK293 cells and hereditary stomatocytosis red blood cells.

Frumence E, Genetet S, Ripoche P, Iolascon A, Andolfo I, Le Van Kim C, Colin Y, Mouro-Chanteloup I, Lopez C.

Am J Physiol Cell Physiol. 2013 Sep 15;305(6):C654-62. doi: 10.1152/ajpcell.00142.2013. Epub 2013 Jul 10.

25.

Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1.

Andolfo I, Alper SL, De Franceschi L, Auriemma C, Russo R, De Falco L, Vallefuoco F, Esposito MR, Vandorpe DH, Shmukler BE, Narayan R, Montanaro D, D'Armiento M, Vetro A, Limongelli I, Zuffardi O, Glader BE, Schrier SL, Brugnara C, Stewart GW, Delaunay J, Iolascon A.

Blood. 2013 May 9;121(19):3925-35, S1-12. doi: 10.1182/blood-2013-02-482489. Epub 2013 Mar 11.

26.

MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines.

de Antonellis P, Liguori L, Falanga A, Carotenuto M, Ferrucci V, Andolfo I, Marinaro F, Scognamiglio I, Virgilio A, De Rosa G, Galeone A, Galdiero S, Zollo M.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Apr;386(4):287-302. doi: 10.1007/s00210-013-0837-4. Epub 2013 Jan 26.

PMID:
23354452
27.

Missense mutations in the ABCB6 transporter cause dominant familial pseudohyperkalemia.

Andolfo I, Alper SL, Delaunay J, Auriemma C, Russo R, Asci R, Esposito MR, Sharma AK, Shmukler BE, Brugnara C, De Franceschi L, Iolascon A.

Am J Hematol. 2013 Jan;88(1):66-72. doi: 10.1002/ajh.23357. Epub 2012 Nov 24.

28.

Identification and characterization of the first SLC11A2 isoform 1a mutation causing a defect in splicing process and an hypomorphic allele expression of the SLC11A2 gene.

De Falco L, Bruno M, Andolfo I, David BP, Girelli D, Di Noce F, Camaschella C, Iolascon A.

Br J Haematol. 2012 Nov;159(4):492-5. doi: 10.1111/bjh.12062. Epub 2012 Sep 27. No abstract available.

PMID:
23016933
29.

Identification of ALK germline mutation (3605delG) in pediatric anaplastic medulloblastoma.

Coco S, De Mariano M, Valdora F, Servidei T, Ridola V, Andolfo I, Oberthuer A, Tonini GP, Longo L.

J Hum Genet. 2012 Oct;57(10):682-4. doi: 10.1038/jhg.2012.87. Epub 2012 Jul 19.

PMID:
22810114
30.

The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.

Andolfo I, Liguori L, De Antonellis P, Cusanelli E, Marinaro F, Pistollato F, Garzia L, De Vita G, Petrosino G, Accordi B, Migliorati R, Basso G, Iolascon A, Cinalli G, Zollo M.

Neuro Oncol. 2012 May;14(5):596-612. doi: 10.1093/neuonc/nos002. Epub 2012 Mar 12.

31.

The metallophosphodiesterase Mpped2 impairs tumorigenesis in neuroblastoma.

Liguori L, Andolfo I, de Antonellis P, Aglio V, di Dato V, Marino N, Orlotti NI, De Martino D, Capasso M, Petrosino G, Schramm A, Navas L, Tonini GP, Eggert A, Iolascon A, Zollo M.

Cell Cycle. 2012 Feb 1;11(3):569-81. doi: 10.4161/cc.11.3.19063. Epub 2012 Feb 1.

PMID:
22262177
32.

MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.

de Antonellis P, Medaglia C, Cusanelli E, Andolfo I, Liguori L, De Vita G, Carotenuto M, Bello A, Formiggini F, Galeone A, De Rosa G, Virgilio A, Scognamiglio I, Sciro M, Basso G, Schulte JH, Cinalli G, Iolascon A, Zollo M.

PLoS One. 2011;6(9):e24584. doi: 10.1371/journal.pone.0024584. Epub 2011 Sep 12.

33.

Correlation of NM23-H1 cytoplasmic expression with metastatic stage in human prostate cancer tissue.

Andolfo I, De Martino D, Liguori L, Petrosino G, Troncone G, Tata N, Galasso A, Roma C, Chiancone F, Zarrilli S, Arrigoni G, Staibano S, Imbimbo C, Zollo M.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Oct;384(4-5):489-98. doi: 10.1007/s00210-011-0645-7. Epub 2011 May 7.

PMID:
21553004
34.

Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma.

Andolfo I, Petrosino G, Vecchione L, De Antonellis P, Capasso M, Montanaro D, Gemei M, Troncone G, Iolascon A, Orditura M, Ciardiello F, De Vita F, Zollo M.

BMC Cancer. 2011 Apr 11;11:126. doi: 10.1186/1471-2407-11-126.

35.

Chromosome 9q and 16q loss identified by genome-wide pooled-analysis are associated with tumor aggressiveness in patients with classic medulloblastoma.

Coco S, Valdora F, Bonassi S, Scaruffi P, Stigliani S, Oberthuer A, Berthold F, Andolfo I, Servidei T, Riccardi R, Basso E, Iolascon A, Tonini GP.

OMICS. 2011 May;15(5):273-80. doi: 10.1089/omi.2010.0103. Epub 2011 Feb 24.

PMID:
21348762
36.

Regulation of divalent metal transporter 1 (DMT1) non-IRE isoform by the microRNA Let-7d in erythroid cells.

Andolfo I, De Falco L, Asci R, Russo R, Colucci S, Gorrese M, Zollo M, Iolascon A.

Haematologica. 2010 Aug;95(8):1244-52. doi: 10.3324/haematol.2009.020685. Epub 2010 Apr 21.

37.

SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells.

Persico M, Russo R, Persico E, Svelto M, Spano D, Andolfo I, La Mura V, Capasso M, Tiribelli C, Torella R, Iolascon A.

Clin Chem Lab Med. 2009;47(10):1217-25. doi: 10.1515/CCLM.2009.280.

PMID:
19803812
38.

MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma.

Garzia L, Andolfo I, Cusanelli E, Marino N, Petrosino G, De Martino D, Esposito V, Galeone A, Navas L, Esposito S, Gargiulo S, Fattet S, Donofrio V, Cinalli G, Brunetti A, Vecchio LD, Northcott PA, Delattre O, Taylor MD, Iolascon A, Zollo M.

PLoS One. 2009;4(3):e4998. doi: 10.1371/journal.pone.0004998. Epub 2009 Mar 24.

Supplemental Content

Loading ...
Support Center